It has been about a month since the last earnings report for Humana (HUM). Shares have lost about 8.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading ...

Humana raised its 2025 guidance alongside the release of second quarter results that beat analyst expectations on Wednesday. It’s a bright spot for investors in the health insurance sector following ...

Shares of health insurance company Humana (NYSE:HUM) jumped 11.9% in the afternoon session after the stock continued to rally as the company provided a positive update on its Medicare Advantage "star" ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. When Humana was looking to deepen its presence in the San ...

Humana Inc.'s Q4 and full-year 2024 earnings report shows a 10% revenue increase but significant losses, highlighting major structural issues in its business model. Rising healthcare utilization and ...

Humana stock plummeted 21% on January 27. Humana is a "pure play" on Medicare Advantage—around 85% of their operations. Following CMS’s announcement of a 0.09% rate increase for 2027, HUM experienced ...

Throughout the last three months, 8 analysts have evaluated Humana (NYSE:HUM), offering a diverse set of opinions from bullish to bearish. The following table provides a quick overview of their recent ...

We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands against the other non-tech ...

We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at where Humana Inc. (NYSE:HUM) stands against other top falling stocks with ...

Humana faces severe headwinds from rising medical costs and a dramatic drop in 4-STAR Medicare Advantage membership, pressuring margins and profitability. Learn more about HUM stock here.